Presence of human papillomavirus DNA and abnormal p53 protein accumulation in lung carcinoma

Thorax

Volumn 51, Issue 9, 1996, Pages 887-893

  Soini, Ylermi ^a,b   Nuorva, Kyösti ^a   Kamel, Dia ^a   Pöllänen, Raimo ^a   Vähäkangas, Kirsi ^a   Lehto, Veli Pekka ^a,b   Pääkkö, Paavo ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Carcinoma; Lung; p53; Papillomavirus; Tumour suppressor genes

Indexed keywords

PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LUNG CARCINOMA; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VIRUS DETECTION;

EID: 0029757113     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.9.887     Document Type: Article

References (37)

1. Hollstein M, Sidransky D, Vogelstein B, Harris C. p53 mutations in human cancers. Science 1991;253:49-53.
2. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Clearly K, et al. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989;342:705-8.
3. Deppert W, Buschhausen-Denker G, Patschinsky T, Steinmeyer K. Cell cycle control of p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. II. Requirement for cell cycle progression. Oncogene 1990; 5:1701-6.
4. Milner J. The role of p53 in normal control of cell proliferation. Curr Opin Cell Biol 1991;3:282-6.
5. Farmer G, Bargonetli J, Zhu H, Friedman P, Prywes R, Prives C. Wild-type p53 activates transcription in vitro. Nature 1992;358:83-6.
6. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Induction of apoptosis by wild type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 1992; 89:4495-9.
7. Maltzman W, Czyzyk L. UV-irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 1984;4:1689-94.
8. Hall PA, McKee PH, Menage H, Dover R, Lane DP. High levels of p53 protein in UV irradiated normal human skin. Oncogene 1993;8:203-7.
9. Lane DP. p53, guardian of the genome. Nature 1992; 358:15-16.
10. Levine AJ. The p53 tumour suppressor gene and product. Cancer surveys. Vol 12. Tumour suppressor genes, the cell cycle and cancer. New York:Cold Spring Harbor Laboratory Press,1992:59-79.
11. Montenarh M. Biochemical properties of the growth suppressor/oncoprotein p53. Oncogene 1992;7:1673-80.
12. Bartkova J, Bartek J, Lukas J, Voijtesek B, Staskova Z, Rejthar A, et al. p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. Int J Cancer 1991;49:196-202.
13. Midgley CA, Fisher CJ, Bartek J, Vojtesek B, Lane D, Barnes DM. Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J Cell Sci 1992;101:183-9.
14. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-36.
15. Crook T, Wrede D, Tidy J, Scholefield J, Crawford L, Vousden K. Status of c-myc, p53 and retinoblastoma genes in human papillomavirus positive and negative squamous cell carcinomas of the anus. Oncogene 1991;6:1251-7.
16. Crook T, Wrede D, Vousden KH. p53 point mutation in HPV negative human carcinoma cell lines. Oncogene 1991; 6:873-5.
17. zur Hausen H. Papillomavirus/host cell interactions in the pathogenesis of anogenital cancer. Origins of human cancer: a comprehensive review. New York: Cold Spring Harbor Laboratory Press,1991:685-705.
18. Brachman DG, Graves D, Vokes E, Beckett M, Haraf D, Montag A,. et al. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res 1992;52:4832-6.
19. Rotola A, Monini P, Di Luca D, Savioli A, Simone R, Secchiero P, et al. Presence and physical state of HPV DNA in prostate and urinary tract tissues. Int J Cancer 1992; 52:359-65.
20. Yousem SA, Ohori NP, Sonmez-Alpan E. Occurrence of human papillomavirus DNA in primary lung neoplasms. Cancer 1992;69:693-7.
21. Crook T, Wrede D, Tidy JA, Mason WT, Evans DJ, Vousden KH. Clonal p53 mutation in primary cervical cancer: association with human-papillomavirus-negative tumours. Lancet 1992;339:1070-3.
22. World Health Organization Histological Typing of Lung Tumours. International classification of tumours No 1. Geneva:World Health Organization, 1981.
23. Pöllänen R, Soini Y, Vähäkangas K, Pääkkö P, Lehto V-P. Aberrant p53 protein expression in cervical intra-epithelial neoplasia. Histopathology 1993;23:471-4.
24. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 1989;7:209-14.
25. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HE, et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230:1350-4.
26. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981; 29:577-80.
27. Vojtesek B, Bartek J, Midgley CA, Lane DP. An immunohistochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 1992; 151:237-44.
28. Stephen CW, Lane DP. Mutant conformation of p53. Precise epitope mapping using a filamentous phage epitope library. J Mol Biol 1992;225:577-83.
29. Soini Y, Pääkkö P, Nuorva K, Kamel D, Lane DP, Vähäkangas K. Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas. Virchows Arch [A] 1992;421:223-8.
30. Kinoshita I, Dosaka-Akita H, Shindoh M, Fujino M, Akie, K, Kato M, et al. Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung. Br J Cancer 1995; 71:344-9.
31. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990;248:76-9.
32. Munger K, Scheffner M, Huibregtse JM, Howley PM. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. Cancer surveys. Vol 12. Tumor suppressor genes, the cell cycle and cancer. New York:Cold Spring Harbor Laboratory Press, 1992:197-217.
33. De Villiers, E-M. Heterogeneity of human papillomavirus group. J Virol 1989;6:4898-903.
34. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 55:4855-78.
35. Harris CC, Hollstein M. Clinical implications of the p53 tumor suppressor gene. N Engl J Med 1993;329:1318-27.
36. + p53 conformation. Oncogene 1993;8:2847-51.
37. Nuorva K, Soini Y, Kamel D, Pöllänen R, Bloigu R, Vähäkangas K, Pääkkö P. p53 protein accumulation and the presence of human papillomavirus DNA in bronchiolo-alveolar carcinoma correlate with poor prognosis. Int J Cancer 1995;64:424-9.